# Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects

> **NCT01437592** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 24 (actual)

## Conditions studied

- Diabetes
- Healthy

## Interventions

- **DRUG:** insulin degludec

## Key facts

- **NCT ID:** NCT01437592
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-06
- **Primary completion:** 2011-11-22
- **Final completion:** 2011-11-22
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437592, "Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01437592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*